Variant position: 1040 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 1214 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human VVLLLVIFLLVANILLVNLL IAMFSYTFGKVQGNSDLYWKA
Mouse VVLLLIVFLLVANILLLNLL IAMFSYTFSKVHGNSDLYWKA
Rat VVLLLIVFLLVANILLLNLL IAMFSYTFNKVHGNSDLYWKA
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
1 – 1214 Transient receptor potential cation channel subfamily M member 4
1020 – 1040 Helical
1059 – 1059 K -> Q. Does not affect PIP2-binding.
1034 – 1070
Gain-of-Function Mutations in TRPM4 Activation Gate Cause Progressive Symmetric Erythrokeratodermia.
Wang H.; Xu Z.; Lee B.H.; Vu S.; Hu L.; Lee M.; Bu D.; Cao X.; Hwang S.; Yang Y.; Zheng J.; Lin Z.;
J. Invest. Dermatol. 139:1089-1097(2019)
Cited for: FUNCTION; INVOLVEMENT IN EKVP6; TISSUE SPECIFICITY; VARIANTS EKVP6 MET-1033 AND THR-1040; CHARACTERIZATION OF VARIANTS EKVP6 MET-1033 AND THR-1040;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.